ORCHARD PARK, N.Y., Nov. 19 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF), announced today the Company will hold an investor conference call to discuss current business conditions on Tuesday, November 25, 2008 at 11:00 am ET. The toll free call in number is (866) 901-2585. The international call in number is (404) 835-7099.
Contact: Charles R. Trego, Jr., Executive Vice President & Chief Financial Officer email@example.com (716) 855-1068 http://www.minrad.com
About the Company
The Company is an interventional pain management company with three focus areas: (1) anesthesia and analgesia, (2) real-time image guidance, and (3) conscious sedation. The Company's products are sold throughout the world. The anesthesia and analgesia business currently manufactures and sells generic inhalation anesthetics that are used for human and veterinary surgical procedures. The Company manufactures patented real-time image guidance technologies that facilitate minimally invasive surgery. The SabreSource(TM) system and the accompanying Light Sabre(TM) disposable products have broad applications in orthopedics, neurosurgery, interventional radiology and anesthesia. They enable improved accuracy and reduced radiation in interventional procedures and support the transfer of these procedures to the outpatient setting. The Company is in the process of developing a drug /drug delivery system for the use of halogenated ethers as inhalation analgesics for conscious sedation.
|SOURCE MINRAD International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved